These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 25052561)
21. A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancer. Fang P; Mick R; Deville C; Both S; Bekelman JE; Christodouleas JP; Guzzo TJ; Tochner Z; Hahn SM; Vapiwala N Cancer; 2015 Apr; 121(7):1118-27. PubMed ID: 25423899 [TBL] [Abstract][Full Text] [Related]
22. Proton Therapy for Craniopharyngioma - An Early Report from a Single European Centre. Ajithkumar T; Mazhari AL; Stickan-Verfürth M; Kramer PH; Fuentes CS; Lambert J; Thomas H; Müller H; Fleischhack G; Timmermann B Clin Oncol (R Coll Radiol); 2018 May; 30(5):307-316. PubMed ID: 29459099 [TBL] [Abstract][Full Text] [Related]
23. Comparison of multimodal surgical and radiation treatment methods for pediatric craniopharyngioma: long-term analysis of progression-free survival and morbidity. Ravindra VM; Okcu MF; Ruggieri L; Frank TS; Paulino AC; McGovern SL; Horne VE; Dauser RC; Whitehead WE; Aldave G J Neurosurg Pediatr; 2021 Aug; 28(2):152-159. PubMed ID: 34049281 [TBL] [Abstract][Full Text] [Related]
24. Long-term outcomes and complications in patients with craniopharyngioma: the British Columbia Cancer Agency experience. Lo AC; Howard AF; Nichol A; Sidhu K; Abdulsatar F; Hasan H; Goddard K Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1011-8. PubMed ID: 24661653 [TBL] [Abstract][Full Text] [Related]
25. Assessment of organ dose reduction and secondary cancer risk associated with the use of proton beam therapy and intensity modulated radiation therapy in treatment of neuroblastomas. Fuji H; Schneider U; Ishida Y; Konno M; Yamashita H; Kase Y; Murayama S; Onoe T; Ogawa H; Harada H; Asakura H; Nishimura T Radiat Oncol; 2013 Nov; 8():255. PubMed ID: 24180282 [TBL] [Abstract][Full Text] [Related]
26. Long-term outcomes for adult craniopharyngioma following radiation therapy. Masson-Cote L; Masucci GL; Atenafu EG; Millar BA; Cusimano M; Croul S; Mason W; Laperriere NJ; Sahgal A Acta Oncol; 2013 Jan; 52(1):153-8. PubMed ID: 22568405 [TBL] [Abstract][Full Text] [Related]
27. Mixed-beam approach in locally advanced nasopharyngeal carcinoma: IMRT followed by proton therapy boost versus IMRT-only. Evaluation of toxicity and efficacy. Alterio D; D'Ippolito E; Vischioni B; Fossati P; Gandini S; Bonora M; Ronchi S; Vitolo V; Mastella E; Magro G; Franco P; Ricardi U; Krengli M; Ivaldi G; Ferrari A; Fanetti G; Comi S; Tagliabue M; Verri E; Ricotti R; Ciardo D; Jereczek-Fossa BA; Valvo F; Orecchia R Acta Oncol; 2020 May; 59(5):541-548. PubMed ID: 32090645 [No Abstract] [Full Text] [Related]
28. Predicted Rate of Secondary Malignancies Following Adjuvant Proton Versus Photon Radiation Therapy for Thymoma. Vogel J; Lin L; Litzky LA; Berman AT; Simone CB Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):427-433. PubMed ID: 28871993 [TBL] [Abstract][Full Text] [Related]
29. Dosimetric comparison to the heart and cardiac substructure in a large cohort of esophageal cancer patients treated with proton beam therapy or Intensity-modulated radiation therapy. Shiraishi Y; Xu C; Yang J; Komaki R; Lin SH Radiother Oncol; 2017 Oct; 125(1):48-54. PubMed ID: 28917586 [TBL] [Abstract][Full Text] [Related]
30. Updated Analysis of Comparative Toxicity of Proton and Photon Radiation for Prostate Cancer. Yu JB; DeStephano DM; Jeffers B; Horowitz DP; Soulos PR; Gross CP; Cheng SK J Clin Oncol; 2024 Jun; 42(16):1943-1952. PubMed ID: 38507655 [TBL] [Abstract][Full Text] [Related]
35. Dosimetric comparison between proton beam therapy and photon radiation therapy for locally advanced esophageal squamous cell carcinoma. Hirano Y; Onozawa M; Hojo H; Motegi A; Zenda S; Hotta K; Moriya S; Tachibana H; Nakamura N; Kojima T; Akimoto T Radiat Oncol; 2018 Feb; 13(1):23. PubMed ID: 29426342 [TBL] [Abstract][Full Text] [Related]
36. Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas. Minniti G; Saran F; Traish D; Soomal R; Sardell S; Gonsalves A; Ashley S; Warrington J; Burke K; Mosleh-Shirazi A; Brada M Radiother Oncol; 2007 Jan; 82(1):90-5. PubMed ID: 17161483 [TBL] [Abstract][Full Text] [Related]
37. Proton therapy and limited surgery for paediatric and adolescent patients with craniopharyngioma (RT2CR): a single-arm, phase 2 study. Merchant TE; Hoehn ME; Khan RB; Sabin ND; Klimo P; Boop FA; Wu S; Li Y; Burghen EA; Jurbergs N; Sandler ES; Aldana PR; Indelicato DJ; Conklin HM Lancet Oncol; 2023 May; 24(5):523-534. PubMed ID: 37084748 [TBL] [Abstract][Full Text] [Related]
38. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas. Boehling NS; Grosshans DR; Bluett JB; Palmer MT; Song X; Amos RA; Sahoo N; Meyer JJ; Mahajan A; Woo SY Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):643-52. PubMed ID: 21277111 [TBL] [Abstract][Full Text] [Related]
39. Imaging Changes in Pediatric Intracranial Ependymoma Patients Treated With Proton Beam Radiation Therapy Compared to Intensity Modulated Radiation Therapy. Gunther JR; Sato M; Chintagumpala M; Ketonen L; Jones JY; Allen PK; Paulino AC; Okcu MF; Su JM; Weinberg J; Boehling NS; Khatua S; Adesina A; Dauser R; Whitehead WE; Mahajan A Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):54-63. PubMed ID: 26279024 [TBL] [Abstract][Full Text] [Related]
40. Carbon ion radiation therapy for sinonasal malignancies: Promising results from 2282 cases from the real world. Zhang W; Hu W; Hu J; Gao J; Yang J; Kong L; Lu JJ Cancer Sci; 2020 Dec; 111(12):4465-4479. PubMed ID: 32936975 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]